Assura PLC Annual Report & Notice of AGM (3925B)

TIDMAGR

RNS Number : 3925B

Assura PLC

02 June 2023

2 June 2023

Assura plc

Annual Report & Notice of AGM

Assura plc ("Assura"), the leading primary care property investor and developer, is pleased to announce that the Annual General Meeting ("AGM") will be held on Thursday 6 July 2023 at 11am BST.

The Annual Report and Accounts for the year ended 31 March 2023 and the Notice of AGM will be posted to shareholders today.

In accordance with Listing Rule 9.6.1, copies of these documents have also been submitted to the UK Listing Authority via the National Storage Mechanism and will be available for viewing shortly at https://data.fca.org.uk/#/nsm/nationalstoragemechanism and can also be found on the Company's website at http://assuraplc.com/investor-relations/reports-and-presentations/ .

Shareholders will be able to watch the AGM over the online Investor Meet Company platform by registering in advance via the following link:

https://www.investormeetcompany.com/assura-plc/register-investor

Shareholders are invited to submit any questions in respect of the business of the AGM for the Board to consider. Questions may be submitted in advance over the Investor Meet Company platform following registration and the Board will aim to respond to any such questions relevant to the business of the AGM. Further information is set out in the Notice of AGM.

Shareholders wishing to vote at the AGM are strongly encouraged to do so by completing a Form of Proxy as appropriate. Shareholders will not be able to vote at the meeting over the online platform.

- ENDS -

 
  Assura plc                          Tel: [phone] 
   Orla Ball, Company Secretary        E mail: [e-mail] 
   David Purcell, Investor Relations 
   Director 
  FGS Global                          Tel: [phone] 
   Gordon Simpson                      Email: [e-mail] 
   James Thompson 
 

Notes to Editors

Assura plc is a national healthcare premises specialist and UK REIT based in Warrington, UK - caring for more than 600 primary healthcare buildings, from which over six million patients are served.

A constituent of the FTSE 250 and the EPRA* indices, as at 31 March 2023, Assura's portfolio was valued at GBP2.7 billion.

At Assura, we BUILD for health. Assura builds better spaces for people and places, invests in skills and inspires new ways of working, and unlocks the power of design and innovation to deliver lasting impact for communities - aiming for six million people to have benefitted from improvements to and through its healthcare buildings by 2026.

Assura is leading for a sustainable future, targeting net zero carbon across its portfolio by 2040.

Further information is available at www.assuraplc.com

*EPRA is a registered trademark of the European Public Real Estate Association.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NOAEALKFEFXDEFA

(END) Dow Jones Newswires

June 02, 2023 02:00 ET (06:00 GMT)